2007/055 NICE appraisal of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis
The National Institute for Health and Clinical Excellence (NICE) has today (24 October) published final guidance on the use of the tumour necrosis factor alpha (TNF-α) inhibitors adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis.
 |
2007/053 NICE appraisal of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis 24 October 2007 (42.6Kb 15sec @ 28.8Kbps) |
